UNSPSC 41181547: Low-density lipoprotein immunological test system

In this classification, a Low-density lipoprotein immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Low-density lipoprotein. US FDA regulates Low-density lipoprotein immunological test system under 21 CFR 866.5600 and under FDA product code DFC.

UNSPSC 41181547 Low-density lipoprotein immunological test system is a Commodity code, but the recent state and local contract opportunities posted under this code show little alignment with its nominal scope. The code name references clinical laboratory immunoassay systems for lipid panel testing, yet the opportunities solicited include optical surface profilometry (Valencia College), airfield photometric testing (Lee County Port Authority), drug discovery software licensing (Jackson State University), electric meter test equipment (City of Ocala), high-voltage capacitance measurement modules (Kissimmee Utility Authority), process instrumentation for water and wastewater systems (Collier County), laboratory water quality analyzers (City of Tampa), and atmospheric gas detection systems (City of Phoenix). The issuing bodies span community colleges, airport authorities, universities, municipal utilities, county water departments, and city water quality programs across Florida, Texas, Colorado, Oregon, and Arizona, with no repeat buyers of the same commodity within the recent window.

The persistent mismatch between the code's clinical laboratory testing scope and the actual procurement activity—which centers on specialized instrumentation, environmental monitoring equipment, and software for scientific and engineering applications—suggests either systematic miscoding by state and local procurement offices or a taxonomy alignment issue at the data source. Absent recent opportunities that actually solicit low-density lipoprotein test systems or related clinical chemistry reagents and instrumentation from healthcare providers, public health laboratories, or clinical facilities, this code shows no meaningful activity in the current state and local market. Business development professionals evaluating pursuit should confirm whether their firm's LDL testing products and services are truly being sought under this code or whether relevant opportunities are tagged elsewhere in the UNSPSC hierarchy.